Endogenous retrovirus group FRD member 1 is a potential biomarker for prognosis and immunotherapy for kidney renal clear cell carcinoma.

Frontiers in cellular and infection microbiology(2023)

引用 0|浏览4
暂无评分
摘要
To sum up, our study suggests that ERVFRD-1 plays a role in regulating immunological activity within the tumor microenvironment and is associated with overall survival in KIRC patients. ERVFRD-1 may therefore be a sensitive biomarker for diagnosis, immunotherapy, and prognosis assessment of KIRC.
更多
查看译文
关键词
endogenous retrovirus, biomarker, immunotherapy, kidney renal clear cell carcinoma, bioinformatics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要